Please provide your email address to receive an email when new articles are posted on . Patients were more likely to achieve sustained remission with sarilumab vs. placebo. The most common adverse ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved sarilumab for the treatment of polymyalgia rheumatica in adults who have experienced an ...

The U.S. Food and Drug Administration (FDA) has approved a new biologic treatment option for patients with a common inflammatory disorder known as polymyalgia rheumatica (PMR) who don’t do well with ...

Findings showed secukinumab demonstrated statistically significant and clinically meaningful sustained remission at week 52 vs placebo. Topline data were announced from a phase 3 trial evaluating ...

Polymyalgia rheumatica (PMR) causes symptoms similar to those of several other conditions, such as rheumatoid arthritis, lupus, and fibromyalgia. For this reason, doctors can misdiagnose it. PMR ...

DEAR DR. ROACH: I was recently diagnosed with polymyalgia rheumatica after weeks of intense muscle pain. I’m a 67-year-old female in otherwise good health. My doctor prescribed prednisone, which ...

Baricitinib can effectively treat polymyalgia rheumatica (PMR) without the use of oral glucocorticoids, according to results from a small, randomized, double-blind, placebo-controlled study. Among the ...

Polymyalgia rheumatica (PMR) and rheumatoid arthritis (RA) are both autoimmune conditions that involve the immune system attacking the joints. While both conditions share symptoms like joint pain and ...

Polymyalgia rheumatica (PMR) is an inflammatory disease that causes pain and stiffness in major muscle groups of your body, often including your neck, shoulders, and hip area. It’s the most common ...